cytarabine has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casto, BC; Dipaolo, JA; Janosko, N; Pieczynski, WJ | 1 |
| Higashikuni, N; Sutou, S | 1 |
| Duesberg, P; Hehlmann, R; Kraemer, A; Li, R; Rasnick, D; Rausch, C; Willer, A; Yerganian, G | 1 |
3 other study(ies) available for cytarabine and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Significance of treatment interval and DNA repair in the enhancement of viral transformation by chemical carcinogens and mutagens.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Acetoxyacetylaminofluorene; Adenoviridae; Aflatoxins; Benzopyrenes; Caffeine; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cytarabine; DNA Repair; DNA Replication; Methyl Methanesulfonate; Methylcholanthrene; Methylnitronitrosoguanidine; Mutagens; Oncogenic Viruses; Propiolactone | 1976 |
An optimal, generalized sampling time of 30 +/- 6 h after double dosing in the mouse peripheral blood micronucleus test.
Topics: 2-Acetylaminofluorene; 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carcinogens; Colchicine; Cyclophosphamide; Cytarabine; Floxuridine; Fluorouracil; Kinetics; Methotrexate; Mice; Mice, Inbred Strains; Micronucleus Tests; Mitomycin; Mutagens; Reticulocytes; Sulfuric Acid Esters; Time Factors | 1995 |
Aneuploidy precedes and segregates with chemical carcinogenesis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Aneuploidy; Animals; Carcinogens; Cell Line, Transformed; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; Cricetulus; Cytarabine; DNA Mutational Analysis; Humans; Karyotyping; Male; Methylcholanthrene; Models, Biological; Neoplasms, Experimental; Precancerous Conditions; Time Factors | 2000 |